These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 33360932)

  • 1. HDAC5 inhibition reduces angiotensin II-induced vascular contraction, hypertrophy, and oxidative stress in a mouse model.
    Bai L; Kee HJ; Choi SY; Seok YM; Kim GR; Kee SJ; Kook H; Jeong MH
    Biomed Pharmacother; 2021 Feb; 134():111162. PubMed ID: 33360932
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Angiotensin II-induced histone deacetylase 5 phosphorylation, nuclear export, and Egr-1 expression are mediated by Akt pathway in A10 vascular smooth muscle cells.
    Truong V; Jain A; Anand-Srivastava MB; Srivastava AK
    Am J Physiol Heart Circ Physiol; 2021 Apr; 320(4):H1543-H1554. PubMed ID: 33606583
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alamandine attenuates angiotensin II-induced vascular fibrosis via inhibiting p38 MAPK pathway.
    Yang C; Wu X; Shen Y; Liu C; Kong X; Li P
    Eur J Pharmacol; 2020 Sep; 883():173384. PubMed ID: 32707188
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Histone deacetylase and GATA-binding factor 6 regulate arterial remodeling in angiotensin II-induced hypertension.
    Kim GR; Cho SN; Kim HS; Yu SY; Choi SY; Ryu Y; Lin MQ; Jin L; Kee HJ; Jeong MH
    J Hypertens; 2016 Nov; 34(11):2206-19. PubMed ID: 27512969
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Histone deacetylase inhibitor LMK235 attenuates vascular constriction and aortic remodelling in hypertension.
    Choi SY; Kee HJ; Sun S; Seok YM; Ryu Y; Kim GR; Kee SJ; Pflieger M; Kurz T; Kassack MU; Jeong MH
    J Cell Mol Med; 2019 Apr; 23(4):2801-2812. PubMed ID: 30734467
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of RhoA/ROCK signaling pathway ameliorates hypoxic pulmonary hypertension via HIF-1α-dependent functional TRPC channels.
    Wang XY; Mo D; Tian W; Liu XX; Zhou YG; Sun Y; Feng YD; Xiao X; Hao XW; Zhang HN; Li C; Cao W; Li XQ
    Toxicol Appl Pharmacol; 2019 Apr; 369():60-72. PubMed ID: 30831131
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diallyl Trisulfide Suppresses Angiotensin II-Induced Vascular Remodeling Via Inhibition of Mitochondrial Fission.
    Lu ZY; Qi J; Yang B; Cao HL; Wang RY; Wang X; Chi RF; Guo CL; Yang ZM; Liu HM; Li B
    Cardiovasc Drugs Ther; 2020 Oct; 34(5):605-618. PubMed ID: 32564303
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vascular smooth muscle Jak2 mediates angiotensin II-induced hypertension via increased levels of reactive oxygen species.
    Kirabo A; Kearns PN; Jarajapu YP; Sasser JM; Oh SP; Grant MB; Kasahara H; Cardounel AJ; Baylis C; Wagner KU; Sayeski PP
    Cardiovasc Res; 2011 Jul; 91(1):171-9. PubMed ID: 21354995
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Calcium/calmodulin-dependent kinase II inhibition in smooth muscle reduces angiotensin II-induced hypertension by controlling aortic remodeling and baroreceptor function.
    Prasad AM; Morgan DA; Nuno DW; Ketsawatsomkron P; Bair TB; Venema AN; Dibbern ME; Kutschke WJ; Weiss RM; Lamping KG; Chapleau MW; Sigmund CD; Rahmouni K; Grumbach IM
    J Am Heart Assoc; 2015 Jun; 4(6):e001949. PubMed ID: 26077587
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Angiotensin II stimulates protein kinase D-dependent histone deacetylase 5 phosphorylation and nuclear export leading to vascular smooth muscle cell hypertrophy.
    Xu X; Ha CH; Wong C; Wang W; Hausser A; Pfizenmaier K; Olson EN; McKinsey TA; Jin ZG
    Arterioscler Thromb Vasc Biol; 2007 Nov; 27(11):2355-62. PubMed ID: 17823368
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Class I histone deacetylase inhibitor MS-275 attenuates vasoconstriction and inflammation in angiotensin II-induced hypertension.
    Ryu Y; Kee HJ; Sun S; Seok YM; Choi SY; Kim GR; Kee SJ; Pflieger M; Kurz T; Kim HS; Jeong MH
    PLoS One; 2019; 14(3):e0213186. PubMed ID: 30830950
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Crucial role of ROCK2 in vascular smooth muscle cells for hypoxia-induced pulmonary hypertension in mice.
    Shimizu T; Fukumoto Y; Tanaka S; Satoh K; Ikeda S; Shimokawa H
    Arterioscler Thromb Vasc Biol; 2013 Dec; 33(12):2780-91. PubMed ID: 24135024
    [TBL] [Abstract][Full Text] [Related]  

  • 13. NRF2 prevents hypertension, increased ADMA, microvascular oxidative stress, and dysfunction in mice with two weeks of ANG II infusion.
    Wang C; Luo Z; Carter G; Wellstein A; Jose PA; Tomlinson J; Leiper J; Welch WJ; Wilcox CS; Wang D
    Am J Physiol Regul Integr Comp Physiol; 2018 Mar; 314(3):R399-R406. PubMed ID: 29167164
    [TBL] [Abstract][Full Text] [Related]  

  • 14. RhoA/ROCK Pathway Activation is Regulated by AT1 Receptor and Participates in Smooth Muscle Migration and Dedifferentiation via Promoting Actin Cytoskeleton Polymerization.
    Qi Y; Liang X; Dai F; Guan H; Sun J; Yao W
    Int J Mol Sci; 2020 Jul; 21(15):. PubMed ID: 32751352
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sex differences and role of lysyl oxidase-like 2 in angiotensin II-induced hypertension in mice.
    Wang H; Martinez Yus M; Brady T; Choi R; Nandakumar K; Smith L; Jang R; Wodu BP; Almodiel JD; Stoddart L; Kim DH; Steppan J; Santhanam L
    Am J Physiol Heart Circ Physiol; 2024 Sep; 327(3):H642-H659. PubMed ID: 39028284
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Negative regulation of RhoA/Rho kinase by angiotensin II type 2 receptor in vascular smooth muscle cells: role in angiotensin II-induced vasodilation in stroke-prone spontaneously hypertensive rats.
    Savoia C; Tabet F; Yao G; Schiffrin EL; Touyz RM
    J Hypertens; 2005 May; 23(5):1037-45. PubMed ID: 15834290
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HDAC5 catalytic activity suppresses cardiomyocyte oxidative stress and NRF2 target gene expression.
    Hu T; Schreiter FC; Bagchi RA; Tatman PD; Hannink M; McKinsey TA
    J Biol Chem; 2019 May; 294(21):8640-8652. PubMed ID: 30962285
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fibroblast Nox2 (NADPH Oxidase-2) Regulates ANG II (Angiotensin II)-Induced Vascular Remodeling and Hypertension via Paracrine Signaling to Vascular Smooth Muscle Cells.
    Harrison CB; Trevelin SC; Richards DA; Santos CXC; Sawyer G; Markovinovic A; Zhang X; Zhang M; Brewer AC; Yin X; Mayr M; Shah AM
    Arterioscler Thromb Vasc Biol; 2021 Feb; 41(2):698-710. PubMed ID: 33054395
    [TBL] [Abstract][Full Text] [Related]  

  • 19. iPLA2β overexpression in smooth muscle exacerbates angiotensin II-induced hypertension and vascular remodeling.
    Calderon LE; Liu S; Su W; Xie Z; Guo Z; Eberhard W; Gong MC
    PLoS One; 2012; 7(2):e31850. PubMed ID: 22363752
    [TBL] [Abstract][Full Text] [Related]  

  • 20. LncRNA-SMILR modulates RhoA/ROCK signaling by targeting miR-141 to regulate vascular remodeling in pulmonary arterial hypertension.
    Lei S; Peng F; Li ML; Duan WB; Peng CQ; Wu SJ
    Am J Physiol Heart Circ Physiol; 2020 Aug; 319(2):H377-H391. PubMed ID: 32559140
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.